mRNA Flu Vaccine Faces FDA Verdict: Approval Alone Won't Mean Coverage for Seniors
One daysingle sourceOne outlet reported this, once - no second voice in this corpus.
All 1 reports on Wed, 5 August 2026
What it is about
Mario Tama GettyEvan AndersonFlor Munoz-RivasHana El SahlyMary LenihanLisa GrohskopfGauri RavalEuropean UnionPanel Unanimously Backs ModernaBaylor College Of MedicineUnited StatesAdvisory Committee On Immunization PracticesBiopharm InternationalAdvisory CommitteeAmericansMassachusetts, United StatesAustraliaAmericanNew York, United StatesCanada
Who published it, and when
How it spread - 1 original report
Wed, 5 August 2026
1 report- techtimes.com13:23first to report
mRNA flu vaccine mFlusiva faces its FDA decision deadline today. Approval will not automatically trigger insurance coverage for patients -- that requires an ACIP recommendation that a March 2026 federal court ruling has made impossible to issue. For adults 65+, head-to-head evidence against Fluzone